Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (Duchenne), Friedreich’s ataxia (FA), catecholaminergic polymorphic ventricular tachycardia (CPVT), TNNT2-mediated dilated cardiomyopathy, BAG3-mediated dilated cardiomyopathy, and additional fatal, genetic cardiac diseases. We are advancing a diverse pipeline and delivery platform in the pursuit of uniting experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted by Duchenne, Solid’s mission is to improve the daily lives of patients living with devastating rare diseases. We are seeking an Executive Director of Government Affairs to lead Solid’s global government engagement and public policy strategy, with a primary focus on the United States. This role is critical to advancing a favorable policy, regulatory, and reimbursement environment for Solid’s neuromuscular and cardiac gene therapies across federal and state stakeholders. The ideal candidate brings deep experience navigating complex healthcare policy issues—including FDA regulation, CMS reimbursement, Medicaid policy, and innovative payment models—and has a strong track record of engagement with policymakers, regulators, and patient advocacy communities. This role will be based in Solid’s Corporate Headquarters located in Hood Park in Charlestown, MA and will work in a hybrid capacity.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive